Pub Date : 2022-03-08DOI: 10.1057/s41292-022-00274-8
Myriam Durocher
{"title":"‘Healthy’ for whom? ‘Healthy’ food’s effectivities, avocados, and the production of differentiated bodies","authors":"Myriam Durocher","doi":"10.1057/s41292-022-00274-8","DOIUrl":"https://doi.org/10.1057/s41292-022-00274-8","url":null,"abstract":"","PeriodicalId":46976,"journal":{"name":"Biosocieties","volume":"18 1","pages":"389-409"},"PeriodicalIF":1.6,"publicationDate":"2022-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41759902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-08DOI: 10.1057/s41292-022-00272-w
M. Smolka
{"title":"Making epistemic goods compatible: knowledge-making practices in a lifestyle intervention RCT on mindfulness and compassion meditation","authors":"M. Smolka","doi":"10.1057/s41292-022-00272-w","DOIUrl":"https://doi.org/10.1057/s41292-022-00272-w","url":null,"abstract":"","PeriodicalId":46976,"journal":{"name":"Biosocieties","volume":"18 1","pages":"359-388"},"PeriodicalIF":1.6,"publicationDate":"2022-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46495659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-25DOI: 10.1057/s41292-021-00267-z
Anja M B Jensen
{"title":"Making it happen: data practices and the power of diplomacy among Danish organ transplant coordinators","authors":"Anja M B Jensen","doi":"10.1057/s41292-021-00267-z","DOIUrl":"https://doi.org/10.1057/s41292-021-00267-z","url":null,"abstract":"","PeriodicalId":46976,"journal":{"name":"Biosocieties","volume":"1 1","pages":"1-20"},"PeriodicalIF":1.6,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42629327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-25DOI: 10.1057/s41292-021-00268-y
B. Kvernflaten, P. Fedorcsak, K. Solbrække
{"title":"It’s all about kids, kids, kids! Negotiating reproductive citizenship and patient-centred care in ‘factory IVF’","authors":"B. Kvernflaten, P. Fedorcsak, K. Solbrække","doi":"10.1057/s41292-021-00268-y","DOIUrl":"https://doi.org/10.1057/s41292-021-00268-y","url":null,"abstract":"","PeriodicalId":46976,"journal":{"name":"Biosocieties","volume":"1 1","pages":"1-21"},"PeriodicalIF":1.6,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43869644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01Epub Date: 2021-05-13DOI: 10.1057/s41292-021-00232-w
Elisa Lievevrouw, Luca Marelli, Ine Van Hoyweghen
As digital health technologies (DHT) have been embraced as a 'panacea' for health care systems, they have evolved from a buzzword into a high priority objective for health policy across the globe. In the realm of quality and safety standards for medical devices, the US Food and Drug Administration (FDA) has been a frontrunner in adapting its regulatory framework to DHT. However, despite the utmost relevance of quality and safety standards and their role for sustaining the innovation pathway of DHT, their actual making has not yet been subjected to in-depth social-science scrutiny. Drawing on the conceptual repertoires of Science and Technology Studies (STS), this article investigates how digital health evolved from a buzzword into an 'object of government', or gained material meaning and transformed into a regulatable object, by charting the standard-making process of FDA's medical digital health policy between 2008 and 2018. From this, we reflect on the mutually sustaining dynamics between technological and organizational innovation, as the FDA's attempts to standardize medical DHT not only shaped the lifestyle/medical boundary for DHT. It also led to significant reconfigurations within the FDA itself, while fostering a broader shift toward the uptake of alternative forms of evidence in regulatory science.
{"title":"The FDA's standard-making process for medical digital health technologies: co-producing technological and organizational innovation.","authors":"Elisa Lievevrouw, Luca Marelli, Ine Van Hoyweghen","doi":"10.1057/s41292-021-00232-w","DOIUrl":"https://doi.org/10.1057/s41292-021-00232-w","url":null,"abstract":"<p><p>As digital health technologies (DHT) have been embraced as a 'panacea' for health care systems, they have evolved from a buzzword into a high priority objective for health policy across the globe. In the realm of quality and safety standards for medical devices, the US Food and Drug Administration (FDA) has been a frontrunner in adapting its regulatory framework to DHT. However, despite the utmost relevance of quality and safety standards and their role for sustaining the innovation pathway of DHT, their actual making has not yet been subjected to in-depth social-science scrutiny. Drawing on the conceptual repertoires of Science and Technology Studies (STS), this article investigates how digital health evolved from a buzzword into an 'object of government', or gained material meaning and transformed into a regulatable object, by charting the standard-making process of FDA's medical digital health policy between 2008 and 2018. From this, we reflect on the mutually sustaining dynamics between technological and organizational innovation, as the FDA's attempts to standardize medical DHT not only shaped the lifestyle/medical boundary for DHT. It also led to significant reconfigurations within the FDA itself, while fostering a broader shift toward the uptake of alternative forms of evidence in regulatory science.</p>","PeriodicalId":46976,"journal":{"name":"Biosocieties","volume":"17 3","pages":"549-576"},"PeriodicalIF":1.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116827/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38993119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01Epub Date: 2021-03-05DOI: 10.1057/s41292-020-00223-3
Robert D Smith
This article traces the history of India's first tertiary cancer hospital, Tata Memorial Hospital (TMH). TMH was originally conceived in 1932 as a philanthropic project by the Tatas, an elite Parsi business family in Bombay. The founding of TMH represented a form of philanthro-capitalism which both enabled the Tatas to foster a communal acceptance for big businesses in Bombay and provide the Tatas with the opportunity to place stakes in the emerging nuclear research economy seen as essential to the scientific nationalist sentiment of the post-colonial state. In doing this, the everyday activities of TMH placed a heavy emphasis on nuclear research. In a time when radium for the treatment of cancer was still seen as 'quackery' in much of the world, the philanthro-capitalist investment and the interest in nuclear research by the post-colonial state provided an environment where radium medicine was able to be validated. The validation of radiotherapy at TMH influenced how other cancer hospitals in India developed and also provided significant resources for cancer research in early-mid twentieth century India. Ultimately, this article identifies ways in which cancer comes to be seen as relevant in the global south and raises questions on the relationship between local and global actors in setting health priorities.
{"title":"Emerging infrastructures: the politics of radium and the validation of radiotherapy in India's first tertiary cancer hospital.","authors":"Robert D Smith","doi":"10.1057/s41292-020-00223-3","DOIUrl":"https://doi.org/10.1057/s41292-020-00223-3","url":null,"abstract":"<p><p>This article traces the history of India's first tertiary cancer hospital, Tata Memorial Hospital (TMH). TMH was originally conceived in 1932 as a philanthropic project by the Tatas, an elite Parsi business family in Bombay. The founding of TMH represented a form of philanthro-capitalism which both enabled the Tatas to foster a communal acceptance for big businesses in Bombay and provide the Tatas with the opportunity to place stakes in the emerging nuclear research economy seen as essential to the scientific nationalist sentiment of the post-colonial state. In doing this, the everyday activities of TMH placed a heavy emphasis on nuclear research. In a time when radium for the treatment of cancer was still seen as 'quackery' in much of the world, the philanthro-capitalist investment and the interest in nuclear research by the post-colonial state provided an environment where radium medicine was able to be validated. The validation of radiotherapy at TMH influenced how other cancer hospitals in India developed and also provided significant resources for cancer research in early-mid twentieth century India. Ultimately, this article identifies ways in which cancer comes to be seen as relevant in the global south and raises questions on the relationship between local and global actors in setting health priorities.</p>","PeriodicalId":46976,"journal":{"name":"Biosocieties","volume":"17 3","pages":"415-441"},"PeriodicalIF":1.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933602/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25451065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01Epub Date: 2021-07-01DOI: 10.1057/s41292-021-00238-4
Scott Berry, John Scott, Matthew Ball, Victor Minichiello
There is little research on how nationalism is adopted and deployed to foster but also to challenge sex-, gender- and HIV-related stigma in Thailand and other nation states across Southeast Asia. The available literature highlights how self-help groups for Thai people with HIV function as communities of practice, as sites of learning, and for gaining and preserving knowledge (Tanabe 2008, Liamputtong 2009, 2014). This article contributes to the literature by demonstrating how collectives of same-sex-attracted men and male-to-female transgender people living with HIV (PLHIV) in Thailand learn and teach each other how to alleviate social and personal barriers that impede access to health care. The study adopted qualitative research methods and interviewed 22 participants in five cities in Thailand. This article highlights how collective action, which adopts and reinterprets the symbols and metaphors of Thai nationalism, acts as a 'deviance disavowal' strategy (Davis 1961). By deploying Thai nationalism, same-sex attracted men and transgender PLHIV reposition 'spoiled identities' and break through the stigma they report after HIV diagnosis. Describing mechanisms of 'deviance disavowal' in Thailand may provide an opportunity to deploy strategies to manage stigma that interferes with access to health care in Thailand, and in other nation states, and may be applicable to other stigmatised groups and illnesses.
{"title":"Deploying nationalist discourses to reduce sex-, gender- and HIV-related stigma in Thailand.","authors":"Scott Berry, John Scott, Matthew Ball, Victor Minichiello","doi":"10.1057/s41292-021-00238-4","DOIUrl":"https://doi.org/10.1057/s41292-021-00238-4","url":null,"abstract":"<p><p>There is little research on how nationalism is adopted and deployed to foster but also to challenge sex-, gender- and HIV-related stigma in Thailand and other nation states across Southeast Asia. The available literature highlights how self-help groups for Thai people with HIV function as communities of practice, as sites of learning, and for gaining and preserving knowledge (Tanabe 2008, Liamputtong 2009, 2014). This article contributes to the literature by demonstrating how collectives of same-sex-attracted men and male-to-female transgender people living with HIV (PLHIV) in Thailand learn and teach each other how to alleviate social and personal barriers that impede access to health care. The study adopted qualitative research methods and interviewed 22 participants in five cities in Thailand. This article highlights how collective action, which adopts and reinterprets the symbols and metaphors of Thai nationalism, acts as a 'deviance disavowal' strategy (Davis 1961). By deploying Thai nationalism, same-sex attracted men and transgender PLHIV reposition 'spoiled identities' and break through the stigma they report after HIV diagnosis. Describing mechanisms of 'deviance disavowal' in Thailand may provide an opportunity to deploy strategies to manage stigma that interferes with access to health care in Thailand, and in other nation states, and may be applicable to other stigmatised groups and illnesses.</p>","PeriodicalId":46976,"journal":{"name":"Biosocieties","volume":" ","pages":"676-694"},"PeriodicalIF":1.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39153359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01Epub Date: 2021-08-19DOI: 10.1057/s41292-021-00240-w
Victoria Boydell, Katharine Dow
The ever-expanding availability of reproductive technologies, the continued roll-out of 'family planning' and maternity services across low- and middle-income settings and the rapid development of the fertility industry mean that it is more likely than ever that individuals, especially women and gender non-conforming people, will engage with more than one RT at some point in their life. These multiple engagements with RTs will affect users' expectations and uptake, as well as the technologies' availability, commercial success, ethical status and social meanings. We argue that an integrated approach to the study of RTs and their users not only makes for better research, but also more politically conscious research, which questions some of the ideological precepts that have led to reproduction being parcelled out into biomedical specialisations and a disproportionate focus on particular forms of reproduction in particular disciplines within public health and social science research. We offer this article as part of a wider movement in the study of reproduction and reproductive technologies, which takes inspiration from the reproductive justice framework to address forms of exclusion, discrimination and stratification that are perpetuated in the development and application of reproductive technologies and the ways in which they are studied and theorised.
{"title":"Adjusting the analytical aperture: propositions for an integrated approach to the social study of reproductive technologies.","authors":"Victoria Boydell, Katharine Dow","doi":"10.1057/s41292-021-00240-w","DOIUrl":"10.1057/s41292-021-00240-w","url":null,"abstract":"<p><p>The ever-expanding availability of reproductive technologies, the continued roll-out of 'family planning' and maternity services across low- and middle-income settings and the rapid development of the fertility industry mean that it is more likely than ever that individuals, especially women and gender non-conforming people, will engage with more than one RT at some point in their life. These multiple engagements with RTs will affect users' expectations and uptake, as well as the technologies' availability, commercial success, ethical status and social meanings. We argue that an integrated approach to the study of RTs and their users not only makes for better research, but also more politically conscious research, which questions some of the ideological precepts that have led to reproduction being parcelled out into biomedical specialisations and a disproportionate focus on particular forms of reproduction in particular disciplines within public health and social science research. We offer this article as part of a wider movement in the study of reproduction and reproductive technologies, which takes inspiration from the reproductive justice framework to address forms of exclusion, discrimination and stratification that are perpetuated in the development and application of reproductive technologies <i>and</i> the ways in which they are studied and theorised.</p>","PeriodicalId":46976,"journal":{"name":"Biosocieties","volume":"17 4","pages":"732-757"},"PeriodicalIF":1.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10275923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01Epub Date: 2021-05-05DOI: 10.1057/s41292-021-00231-x
Christopher James Lawless
This article critically examines UK biometric policymaking by charting the bodies identified by the 2018 Home Office Biometric Strategy as playing key roles in the oversight of biometric data used in law enforcement and other related functions. The article argues that oversight actors are embedded in biometric imaginaries promoted by the UK Home Office and the devolved Scottish administration. By mapping oversight of UK biometrics policy together with developments in Scotland, the article challenges sociotechnical imaginaries studies which assume the power of national governments to project dominant, cohesive and instrumental visions. The article peels away that image to reveal UK biometric policy as located within a patchwork in which embedded commissioners, regulators and advisors challenge biometric imaginaries through interpretive flexibility and standpoint. By identifying technical, operational, legislative and ethical issues, these actors challenge the UK government imaginary and act as channels of critique between it and wider stakeholder communities. The article further challenges assumptions concerning the cohesion of national imaginaries by highlighting a diverging approach to biometric governance in Scotland. The article uses these observations to sketch a means to further characterise the notion of the biometric imaginary and to address biometric policymaking more widely.
本文通过绘制2018年内政部生物识别战略确定的机构在监管执法和其他相关职能中使用的生物识别数据方面发挥关键作用的图表,批判性地审视了英国的生物识别政策制定。这篇文章认为,监管角色嵌入了英国内政部(UK Home Office)和苏格兰自治政府(Scottish administration)倡导的生物识别想象中。通过将英国生物识别政策的监督与苏格兰的发展结合起来,文章挑战了社会技术想象研究,这些研究假设国家政府的权力来投射主导的、有凝聚力的和工具性的愿景。这篇文章剥离了这一形象,揭示了英国生物识别政策的拼凑,其中嵌入的委员、监管机构和顾问通过解释的灵活性和立场挑战了生物识别的想象。通过识别技术、操作、立法和道德问题,这些参与者挑战了英国政府的想象,并充当了它与更广泛的利益相关者社区之间的批评渠道。这篇文章通过强调苏格兰生物识别治理的不同方法,进一步挑战了关于国家想象凝聚力的假设。本文利用这些观察来概述一种方法,以进一步表征生物识别想象的概念,并更广泛地解决生物识别政策制定问题。
{"title":"The evolution, devolution and distribution of UK Biometric Imaginaries.","authors":"Christopher James Lawless","doi":"10.1057/s41292-021-00231-x","DOIUrl":"https://doi.org/10.1057/s41292-021-00231-x","url":null,"abstract":"<p><p>This article critically examines UK biometric policymaking by charting the bodies identified by the 2018 Home Office Biometric Strategy as playing key roles in the oversight of biometric data used in law enforcement and other related functions. The article argues that oversight actors are embedded in biometric imaginaries promoted by the UK Home Office and the devolved Scottish administration. By mapping oversight of UK biometrics policy together with developments in Scotland, the article challenges sociotechnical imaginaries studies which assume the power of national governments to project dominant, cohesive and instrumental visions. The article peels away that image to reveal UK biometric policy as located within a patchwork in which embedded commissioners, regulators and advisors challenge biometric imaginaries through interpretive flexibility and standpoint. By identifying technical, operational, legislative and ethical issues, these actors challenge the UK government imaginary and act as channels of critique between it and wider stakeholder communities. The article further challenges assumptions concerning the cohesion of national imaginaries by highlighting a diverging approach to biometric governance in Scotland. The article uses these observations to sketch a means to further characterise the notion of the biometric imaginary and to address biometric policymaking more widely.</p>","PeriodicalId":46976,"journal":{"name":"Biosocieties","volume":"17 3","pages":"506-526"},"PeriodicalIF":1.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38965171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01Epub Date: 2021-07-03DOI: 10.1057/s41292-021-00237-5
Eva Hilberg
Monoclonal antibodies are revolutionizing cancer treatments, but come at an increasingly problematic price for health services worldwide. This leads to pressing demands for access, as in the case of Kadcyla. In 2015, patients in the United Kingdom invoked the sovereign rights of the Crown in order to demand access to this expensive yet potentially life-saving medicine that had prior been de-listed due to price. This article interprets this campaign as an act of sovereign reassertion against a fundamental exclusion, which, however, ultimately fails to challenge the concrete mechanism enabling this exclusion-intellectual property (IP). By connecting this example to other declarations of molecular sovereignty, the article argues that the use of sovereignty can perpetuate further exclusion. Drawing on the notion of biocoloniality (Schwartz-Marín and Restrepo 2013) it points out that the intellectual property regime contains a deeply embedded fiction of the world as terra nullius, a blank uninhabited canvas ripe for discovery and appropriation. This decontextualised vision of life as property works to exclude populations and patients from playing a significant role in determining the use of technologies and treatments. Instead of countering this fundamental exclusion, the concept of sovereignty further entrenches this assumption and merely contests the assignation of this property.
单克隆抗体正在给癌症治疗带来革命性的变化,但对世界各地的卫生服务来说,代价越来越大。这导致迫切要求进入,Kadcyla的情况就是如此。2015年,英国的患者援引王室的主权权利,要求获得这种昂贵但可能挽救生命的药物,这种药物此前因价格原因被摘牌。本文将这一运动解释为反对基本排斥的主权重申行为,然而,这最终未能挑战实现这种排斥的具体机制-知识产权(IP)。通过将这个例子与其他分子主权宣言联系起来,文章认为,使用主权可以使进一步的排斥永久化。利用生物殖民化的概念(Schwartz-Marín and Restrepo 2013),它指出知识产权制度包含了一个根深蒂固的虚构世界,即无主之地,一个空白的无人居住的画布,成熟的发现和占有。这种将生命视为财产的脱离背景的观点,使人群和患者无法在决定技术和治疗方法的使用方面发挥重要作用。主权的概念不但没有反对这种根本的排斥,反而进一步巩固了这一假设,而且只是对这种财产的分配提出异议。
{"title":"Molecular sovereignties: patients, genomes, and the enduring <i>biocoloniality</i> of intellectual property.","authors":"Eva Hilberg","doi":"10.1057/s41292-021-00237-5","DOIUrl":"https://doi.org/10.1057/s41292-021-00237-5","url":null,"abstract":"<p><p>Monoclonal antibodies are revolutionizing cancer treatments, but come at an increasingly problematic price for health services worldwide. This leads to pressing demands for access, as in the case of <i>Kadcyla.</i> In 2015, patients in the United Kingdom invoked the sovereign rights of the Crown in order to demand access to this expensive yet potentially life-saving medicine that had prior been de-listed due to price. This article interprets this campaign as an act of sovereign reassertion against a fundamental exclusion, which, however, ultimately fails to challenge the concrete mechanism enabling this exclusion-intellectual property (IP). By connecting this example to other declarations of molecular sovereignty, the article argues that the use of sovereignty can perpetuate further exclusion. Drawing on the notion of <i>biocoloniality</i> (Schwartz-Marín and Restrepo 2013) it points out that the intellectual property regime contains a deeply embedded fiction of the world as <i>terra nullius</i>, a blank uninhabited canvas ripe for discovery and appropriation. This decontextualised vision of life as property works to exclude populations and patients from playing a significant role in determining the use of technologies and treatments. Instead of countering this fundamental exclusion, the concept of sovereignty further entrenches this assumption and merely contests the assignation of this property.</p>","PeriodicalId":46976,"journal":{"name":"Biosocieties","volume":" ","pages":"695-712"},"PeriodicalIF":1.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254056/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39173942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}